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This work characterizes a set of lactobacilli strains isolated from the stomach of healthy
humans that might serve as probiotic cultures. Ten different strains were recognized
by rep-PCR and PFGE fingerprinting among 19 isolates from gastric biopsies and
stomach juice samples. These strains belonged to five species, Lactobacillus gasseri
(3), Lactobacillus reuteri (2), Lactobacillus vaginalis (2), Lactobacillus fermentum (2) and
Lactobacillus casei (1). All ten strains were subjected to a series of in vitro tests to assess
their functional and technological properties, including acid resistance, bile tolerance,
adhesion to epithelial gastric cells, production of antimicrobial compounds, inhibition of
Helicobacter pylori, antioxidative activity, antibiotic resistance, carbohydrate fermentation,
glycosidic activities, and ability to grow in milk. As expected, given their origin, all strains
showed good resistance to low pH (3.0), with small reductions in counts after 90min
exposition to this pH. Species- and strain-specific differences were detected in terms of
the production of antimicrobials, antagonistic effects toward H. pylori, antioxidative activity
and adhesion to gastric epithelial cells. None of the strains showed atypical resistance to
a series of 16 antibiotics of clinical and veterinary importance. Two L. reuteri strains were
deemed as the most appropriate candidates to be used as potential probiotics against
microbial gastric disorders; these showed good survival under gastrointestinal conditions
reproduced in vitro, along with strong anti-Helicobacter and antioxidative activities. The
two L. reuteri strains further displayed appropriated technological traits for their inclusion
as adjunct functional cultures in fermented dairy products.
Keywords: stomach microbiota, gastric lactobacilli, specific probiotics, functional characterization, antioxidative
activity, anti-Helicobacter activity, fermentation capability
INTRODUCTION
Over recent decades, culture-independent techniques have
revealed the stomach to be home to a well-adapted, niche-
specific microbial community (Bik et al., 2006; Andersson et al.,
2008; Delgado et al., 2013). Gastric microbial communities are
of potential probiotic use in the treatment of several diseases,
but only a few studies have attempted to cultivate their mem-
bers (Adamson et al., 1999; Li et al., 2009; Delgado et al., 2013).
The isolation and characterization of stomach originated strains
could provide novel probiotic candidates with enhanced capac-
ities to counteract gastric pathogens such as Helicobacter pylori
(Cui et al., 2010). This Gram-negative, microaerophilic microor-
ganism infects over 50% of the population worldwide (Bruce and
Maaroos, 2008). Indeed, H. pylori is the most important aetio-
logical agent in chronic gastritis, peptic ulcers and gastric cancer
(Peek and Blaser, 2002). The eradication (efficiency 80–90%)
of H. pylori is possible using a combination of antibiotics and
antacids. However, side-effects are common. As an alternative or
complementary therapy, or indeed as a preventive strategy, use
might be made of probiotics for the management of this infection
(Malfertheiner et al., 2007). To date, studies have focused on con-
ventional probiotic cultures from different origins. Among these,
Lactobacillus reuteri having anti H. pylori action is one promising
approach (Francavilla et al., 2008).
The aim of the present work was to examine in vitro the func-
tional and technological characteristics of Lactobacillus isolates
recovered from the stomach mucosa and gastric juice of healthy
individuals in a previous study (Delgado et al., 2013) for their
evaluation as probiotics in functional products against H. pylori
infection. Gastric candidate probiotic strains with potential appli-
cation in the prevention and treatment of gastric disorders and
dysbiosis were then selected.
MATERIALS AND METHODS
BACTERIAL ISOLATES AND GROWTH CONDITIONS
Nineteen Lactobacillus isolates belonging to five different species
were cultured from gastric biopsies and stomach juice sam-
ples provided by healthy subjects (see Delgado et al., 2013).
Unless otherwise indicated, all isolates were cultured in de Man,
Rogosa and Sharpe (MRS; Merck, Darmstadt, Germany) medium
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supplemented with 0.25% cysteine (Merck) (MRSC). Incubations
proceeded at 37◦C for 24 h in an anaerobic chamber (Mac500,
Down Whitley Scientific, West Yorkshire, UK) containing an
anoxic atmosphere (10% H2, 10% CO2, 80% N2).
TYPING OF LACTOBACILLI
The isolates were genotyped by repetitive extragenic palindromic
(rep)-PCR and by pulsed-field gel electrophoresis (PFGE)
fingerprinting. For rep-PCR, total DNA from the isolates
was purified from overnight cultures using the GenElute™
Bacterial Genomic DNA Kit (Sigma-Aldrich, St. Louis,
MO, USA), following the manufacturer’s recommendations.
Amplifications were performed using the primer BoxA2-R
(5′-ACGTGGTTTGAAGAGATTTTCG-3′), as reported by
Koeuth et al. (1995). For PFGE, genomic DNA was isolated
and digested at 30◦C for 4 h in agarose plugs containing 20U
of the restriction endonuclease SmaI (Boehringer Mannheim,
Mannheim, Germany). Electrophoresis was performed in 1%
FastLane agarose gels (FMC, Philadelphia, PA, USA) in 0.5X
TBE (Tris-borate-EDTA) for 20 h at 14◦C and at 6 V/cm, using
a CHEF-DRII apparatus (Bio-Rad, Richmond, CA, USA). Pulse
times ranged from 0.1 to 2 s for 4 h, from 2 to 5 s for 12 h, and
from 5 to 10 s for 4 h. Low-range and bacteriophage lambda
ladder PFGE markers (both from New England BioLabs, Ipswich,
MA, USA) were included in the gels.
GASTROINTESTINAL TOLERANCE
Viability at low pH
The ability of the isolates to survive under acidic conditions was
assessed by exposing the cells to an acidic solution. HCl was added
to cell suspensions (≈108 cells/ml) in a sterile saline solution
(0.9%) to achieve pHs ranging from 2.0 to 6.5 (pH 7.0 was used
as a control). The cells were then incubated at 37◦C for 90min.
After incubation the pH of the medium was recorded again and
the viability of the strains assessed by plate counting on MRSC.
Resistance to bile
The tolerance of the strains to bovine bile (Ox-gall, Sigma-
Aldrich) was assayed following the procedure of Charteris et al.
(1998). Briefly, individual colonies from MRSC plates were sus-
pended in 2ml of sterile saline solution until a density corre-
sponding to McFarland standard 1 was obtained. Aliquots of this
suspension (10μl) were spotted onto bile-containing agar plates.
The concentration of bile assayed ranged from 0.25 to 4% (w/v).
PRODUCTION OF ANTIMICROBIAL COMPOUNDS
Anti-Helicobacter pylori activity
H. pylori DSM 10242 was routinely grown in solid or liquid brain
heart infusion medium (BHI; Oxoid, Basingstoke, Hampshire,
UK), supplemented with either 5% (w/v) horse blood (Oxoid) or
10% (w/v) fetal bovine serum (Oxoid), respectively. Inoculated
cultures were then incubated at 37◦C for 3–7 days under the
microaerophilic conditions generated by the CampyGen system
(Oxoid). Antagonistic activity of lactobacilli against H. pylori
was assessed by a broth inhibition assay after growing of the
test strains in Elliker broth (Scharlau, Barcelona, Spain), since
MRS medium inhibits the growth of this pathogen (Ryan et al.,
2008b). Inhibition assays were performed in 96-well, “U”-bottom
polystyrene microtitre plates. Supplemented BHI was inoculated
at 1.5 (v/v) with a concentrated H. pylori culture (OD600 nm 1.0),
and the cell suspension was dispensed into the wells of a
microtitre plate. Then, 45μl of the supernatant of each indi-
vidual lactobacilli strain were added to the wells. As a negative
control, aliquots of non-inoculated Elliker medium were also
tested. The multi-well plates were then incubated for 3 days
under the same conditions as above, and the OD600 nm recorded
using a microplate spectrophotometer (Benchmark; Bio-Rad
Laboratories, Hercules, CA, USA). Assays were also performed
with pH-neutralized supernatants (pH 6.6). All experiments were
repeated twice using independent cultures; all supernatants were
further assayed in triplicate.
Bacteriocins
Bacteriocin production was consecutively examined by an agar
spot test and a well-diffusion assay as previously described
(Delgado et al., 2007), using two well-recognized bacteriocin-
susceptible strains (Lactobacillus sakei CECT 906 and Lactococcus
lactis subsp. lactis IL1403) as indicators.
Hydrogen peroxide (H2O2)
H2O2 production was tested following the procedure described
by Song et al. (1999). MRSC agar plates supplemented with
0.25mg/ml of tetramethylbenzidine (TMB, Sigma-Aldrich) and
0.01mg/ml of horseradish peroxidase (HRP, Sigma-Aldrich) were
inoculated with the strains and incubated at 37◦C under both
aerobic and anaerobic conditions. The presence of any blue pig-
ment in the H2O2–producing colonies was recorded after 2 days.
Lactobacillus jensenii CECT 4306 (Martín and Suárez, 2010) was
used as positive control.
Reuterin
The presence of the gene coding for the large subunit of glyc-
erol dehydratase, which is essential in the production of reuterin
(3-hydroxypropionaldehyde) (Claisse and Lonvaud-Funel, 2001),
was checked for in the Lactobacillus reuteri strains via PCR.
L. reuteri CECT 925, a reuterin-producing strain (Martín et al.,
2005), was used as positive control.
ADHESION TO AN EPITHELIAL GASTRIC CELL LINE
The adhesion of the strains to the gastric mucosa was assessed
in vitro using the gastric cell line AGS (ECACC number 89090402,
Sigma-Aldrich), which is derived from a human gastric adenocar-
cinoma. The latter cells were cultured as per routine in Ham’s F12
medium (LabClinics, Barcelona, Spain) supplemented with 2mM
of L-glutamine (PAA Laboratories GmbH, Paschina, Austria),
10% fetal bovine serum, plus 50μg/ml of penicillin, 50μg/ml of
streptomycin, 50μg/ml of gentamicin, and 1.25μg/ml ampho-
tericin B (Sigma-Aldrich). Monolayers of the cells were prepared
in 24-well tissue culture plates (Becton Dickinson, New Jersey,
USA) at a concentration of 105 cells/ml. After reaching conflu-
ence and differentiating (3 + 1 days), the strains were added at a
ratio 1:1. For this, bacterial cultures were harvested by centrifuga-
tion, washed with Dulbecco’s phosphate-buffered saline solution
(Sigma-Aldrich), and suspended in Ham’s F12 medium without
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antibiotics. After 1 h of co-incubation at 37◦C in a 5% CO2 atmo-
sphere, the monolayers were washed 3 times with a phosphate-
buffered saline solution to remove any non-attached bacteria.
The monolayers were then disrupted with a 0.25% trypsin-EDTA
solution (Sigma-Aldrich), and the attached bacteria enumerated
by standard dilution and plate counting on MRSC. Experiments
were carried out in triplicate and each strain tested in dupli-
cate. The adhesion capacity of the strains was compared to that
of the recognized probiotic strain Lactobacillus rhamnosus ATCC
53103 (strain GG). The results were expressed as the percentage
of adhered bacteria with respect to the initial number of bacteria
added.
ANTIOXIDATIVE ACTIVITY
The total antioxidative activity (TAA) of the gastric lactobacilli
was assessed using the linolenic acid (LA) test, which evaluates the
ability to inhibit lipid peroxidation. Bacterial cultures (24 h) were
centrifuged, washed twice in saline solution, and suspended in the
same solution to an OD600 nm of 1.0. Intact cells in the saline solu-
tion were examined, as were lysates obtained using a cell disruptor
(Constant Systems, Daventry, UK). Reactions were performed
according to the procedure described by Kullisaar et al. (2002),
using 45μl samples (whole cells or lysate). The absorbance
at 534 nm was measured using a UV-Vis Spectrophotometer
(Hitachi High-Technologies, Tokyo, Japan). Intact cells and cell
lysates were assayed in triplicate. The results were expressed as the
percentage of LA oxidation inhibition.
ANTIBIOTIC RESISTANCE
The resistance/susceptibility profiles of the different strains to 16
antibiotics were determined by microdilution using VetMIC™
plates for lactic acid bacteria (LAB) (National Veterinary Institute
of Sweden, Uppsala, Sweden). The strains were grown in LSM
(Klare et al., 2005) agar plates and then suspended in 2ml of ster-
ile saline solution to obtain a density corresponding toMcFarland
standard 1. The suspension was further diluted 1:1000 with LSM,
and 100μl of this inoculum were added to each well. The min-
imum inhibitory concentration (MIC) was defined as the lowest
antibiotic concentration at which no visual growth was observed
after incubation at 37◦C for 48 h.
TECHNOLOGICAL TRAITS
Fermentation capabilities
The carbohydrate fermentation profile of the strains was initially
determined using a miniaturized commercial system (Phene-
Plate, Stockholm, Sweden), following the manufacturer’s instruc-
tions. Growth in the presence of different substrates (lactose,
maltose, trehalose, melibiose and raffinose [all from Sigma-
Aldrich]) was further evaluated by recording the OD600 nm at 24
and 48 h. The strains were inoculated (1% v/v) into a basal fer-
mentation medium (MRS without glucose) supplemented with
2% (w/v) of the carbohydrate under test. All strains had been
previously adapted overnight in the corresponding fermentation
broth.
Glycosidic activity
Enzyme activities were initially measured using the semi-
quantitative API-ZYM system (bioMérieux, Marcy l’Etoile,
France), following the manufacturer’s instructions. Glycosidic
activities in cell-free extracts were confirmed and quantified by
enzyme assays using the p-nitrophenyl (p-NP) derivatives 4-
NP-β-D-glucopyranoside, 4-NP-α-D-glucopyranoside, 4-NP-β-
D-galactopyranoside and 4-NP-α-D-galactopyranoside (all from
Sigma-Aldrich) as substrates. Cells from 20ml cultures in basal
fermentation medium with different inducing carbohydrates
were harvested by centrifugation, washed with 100mM potas-
sium phosphate buffer pH 6.8, and the pellets suspended in 2ml
of the same buffer. Cells were disrupted as above and centrifuged
to remove cell debris. The extracts were then assayed for glyco-
sidic activity. Reactions were performed using 800μl of 40mM
buffer acetate pH 5.5, 100μl of the different p-NP derivatives
at 10mM, and 100μl of the cell-free extracts. Incubation pro-
ceeded for 30min at 37◦C and the reactions were then stopped by
adding 1ml of cold 1M sodium carbonate. After centrifugation,
the absorbance at 410 nm was recorded. The protein content of
cell-free extracts was determined using the BCA protein assay kit
(Pierce, Rockford, IL, USA). Activities were expressed as specific
activity in mU permg of protein. One unit of activity (1U) was
defined as the amount of protein that released 1μmol of p-NP
per min.
Growth and acidification of milk
Overnight cultures, previously washed in a sterile saline solu-
tion, were used to inoculate UHT milk (CAPSA, Siero, Spain)
to provide an initial cell concentration of about 107 cfu/ml. After
incubation at 37◦C in a 5% CO2 atmosphere for 24 and 48 h, bac-
terial counts were performed on MRSC agar plates. The pH of
the inoculated and control milk samples was measured using a
Crison pH-meter (Crison Instruments, Barcelona, Spain) and via
titration with phenolphthalein according to FIL/IDF Standard 86.
RESULTS
TYPING OF GASTRIC LACTOBACILLI STRAINS
The 19 gastric lactobacilli isolates (9 Lactobacillus gasseri, 4
Lactobacillus reuteri, 3 Lactobacillus vaginalis, 2 Lactobacillus fer-
mentum and 1 Lactobacillus casei) were successively typed by
rep-PCR and PFGE (Supplementary Figure 1). The results of
these two techniques agreed well, and 10 different strains were
considered based on their distinct electrophoretic profiles pro-
vided by both methods. The ten selected strains included three
L. gasseri strains (LG52, LG102, and LG123) from two subjects,
two L. reuteri strains (LR32 and LR34) from a single subject, two
L. vaginalis strains (LV51 and LV121) from different subjects, two
genetically unrelated L. fermentum strains (LF1 and LF2) from a
single subject, and a single strain of L. casei (LC71).
FUNCTIONAL PROPERTIES
As a whole, high tolerance to acidity was detected; similar plate
counts were returned by control (pH 7) and treated samples
after exposure to pH 4.5 and above (data not shown). At pH
3 reductions in counts varied among strains but in less than
1 logarithmic unit in all cases (Figure 1). However, at pH 2,
reductions compared to controls counts were between 1 and 3
logarithmic units. The L. gasseri strains were among the most acid
tolerant.
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FIGURE 1 | Viability of the gastric Lactobacillus strains of this study to
acidic conditions after exposure to pH 3 and pH 2 for 90min, as
compared to the control (pH 7.0).
FIGURE 2 | Adhesion ability of gastric lactobacilli to the AGS human
epithelial gastric cell line.
Resistance of the strains to bile varied widely, depending
largely on the species. The L. gasseri strains were the most sus-
ceptible (MICs 0.25–1.5%), followed by those of L. fermentum
(MIC = 1%). The most resistant strains were those of L. reuteri,
L. vaginalis and L. casei, which grew in the presence of 4% bile.
The percentage of adhesion to gastric cells was strain-
dependent but <10% for all strains - even for L. rhamnosus GG
(Figure 2). The most adherent strain was L. casei LC71 (8.5%)
followed by L. reuteri LR32 and L. gasseri LG102.
FIGURE 3 | Growth inhibition of Helicobacter pylori, as determined in
liquid with non-adjusted and pH-neutralized supernatants of the
Lactobacillus strains grown in Elliker medium.
Regarding the bacteriocin-mediated antagonism assays, some
gastric strains of the species L. reuteri, L. gasseri and L. fermentum
were able to slightly inhibit the growth of the indicators in the
agar spot test, although clear halos of inhibition using cell-free,
neutralized supernatants were only observed for L. gasseri LG52
(Supplementary Table 1). The proteinaceous nature of the antimi-
crobial bacteriocin-like substance produced by this strain was
confirmed after treatment of the cell-free supernatants with pro-
teinase K and pronase, both of which eliminated the antibacterial
effect.
On the other hand, the H. pylori inhibitory test revealed all
strains to have some antimicrobial activity against this pathogen,
except for those of L. gasseri (Figure 3). The highest inhibitory
values (∼75%) were obtained for the two L. reuteri strains. When
the supernatants were neutralized, H. pylori growth was sup-
pressed only by the pH-adjusted supernatants pertaining to the
L. reuteri strains, suggesting that the inhibition observed for the
other strains was probably due to the production of organic acids.
Further, the presence of genes associated with reuterin production
(coding for the glycerol dehydratase unit) was revealed by PCR in
the two L. reuteri strains.
As concerns H2O2 production, all L. gasseri strains showed
slight production under aerobic conditions, while the L. vaginalis
and L. reuteri strains clearly produced this substance under both
aerobic and anaerobic conditions (Supplementary Table 1).
Strain-specific differences were also observed with respect to
their TAA, as assessed by the LA test (Table 1). Comparable results
were obtained using either whole cells or cell lysates. Remarkable
activity (TAA>20%)was observed for L. reuteri LR32 and L. vagi-
nalis LV51, and moderate activity (around a 15% reduction of
lipid peroxidation) for L. casei LC71 and L. reuteri LR34. Neither
the L. fermentum strains, nor L. gasseri LG123 and L. vaginalis
LV121 showed any antioxidative activity under the experimental
conditions of this assay.
Atypical antibiotic resistance was not detected for any of the
strains (Table 2). The MICs of the different antibiotics were
always equal to or lower than the microbiological breakpoints
defined by the Panel on Additives and Products or Substances
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used in Animal Feed (FEEDAP) of the European Food Safety
Authority (EFSA, 2012). The exception was kanamycin, for which
a MIC value of 64μg/ml was observed for the two L. fermentum
strains; the EFSA’s breakpoint established for this species is one
dilution lower.
TECHNOLOGICAL TRAITS
Differences were observed between the 10 strains in terms of their
utilization of carbohydrates (Supplementary Table 2). All strains
fermented maltose, and all but L. gasseri LG102 and LG123 fer-
mented sucrose. Lactose was fermented by the single L. casei,
the two L. reuteri, and the two L. fermentum strains. The growth
capacity of the strains in basal fermentation mediumwith lactose,
maltose, threhalose, melibiose and raffinose was further evaluated
by recording the optical density after 24 and 48 h (Figure 4). In
general, and in agreement with the previous results, the L. gasseri
Table 1 | Percentages of total antioxidative activity (TAA) determined
by the linolenic acid test in intact cells and lysates of the gastric
lactobacilli.
Species Strain TAA*
Whole cells (%) Cell extracts (%)
L. gasseri LG52 5 ± 2† 3 ± 1
LG102 16 ± 4 3 ± 1
LG123 0 0
L. reuteri LR32 22 ± 5 23 ± 7
LR34 15 ± 3 14 ± 3
L. vaginalis LV51 32 ± 8 21 ± 4
LV121 0 0
L. fermentum LF71 0 0
LF72 0 0
L. casei LC71 13 ± 4 15 ± 2
*Following the definition by Hütt et al. (2006), the antioxidative effect was
consider significant if the TAA value was >20%.
†Data are expressed as the mean value of three assays ± standard deviation.
strains showed a reduced fermentation capacity compared to
the others. Most of the gastric strains grew in the presence of
maltose and lactose as the sole carbon source. The ability to
grow in trehalose, however, was restricted to a few Lactobacillus
strains (Figure 4). The L. reuteri, L. vaginalis and L. fermentum
strains showed good growth rates in the presence of raffinose and
melibiose.
Nineteen enzymatic activities were tested with the API-ZYM
system. Moderate inter- and intra-species variability on the sub-
strates utilized was observed (Supplementary Table 3). Some
activities were shown by all or most strains and at high levels
(Cys-, Val-, and Leu- arylamidase peptidases, and α- and β-
galactohydrolase activities). In contrast, other activities (such as
those of lipase, trypsin, α-quimotrypsin, α-mamnosidase, and α-
fucosidase) were detected at low levels and only rarely. Glycosidic
activities were also examined in cell-free extracts after growth
of the strains in inducing carbohydrates. These activities may
have a prominent role in key probiotic properties, such as uti-
lization of prebiotics, colonization of the gastric epithelium, etc.
The results are summarized in Table 3. With the exception of
FIGURE 4 | Optical density at 600nm of the lactobacilli strains grown
in basal fermentation medium at 37◦C for 48h using different
carbohydrates: maltose, melibiose, raffinose, lactose and trehalose as
the carbon source (coefficient of variation <10%).
Table 2 | Minimum inhibitory concentration (MIC) values of 16 antibiotics to the gastric lactobacilli strains.
Species Strain Antibiotic* (MIC as μg/ml)
GEN KAN STP NEO TET ERY CLI CHL AMP PEN VAN VIR LIN TRM CIP RIF
L. gasseri LG52 1 32 4 4 4 0.25 1 0.5 0.12 0.06 1 0.5 4 8 64 0.25
LG102 4 32 4 16 2 0.12 0.5 4 0.5 0.12 1 0.5 2 4 64 1
LG123 0.5 32 4 4 2 0.016 0.5 1 0.12 0.06 1 0.25 1 16 16 1
L. reuteri LR32 1 64 16 4 4 0.12 0.03 4 1 0.12 >128 0.5 2 64 64 ≤0.12
LR34 0.5 16 8 0.5 8 0.5 0.12 4 2 0.5 >128 0.5 2 64 32 0.25
L. vaginalis LV51 1 4 2 0.5 1 0.25 0.03 4 0.12 0.12 >128 0.12 1 0.25 32 ≤0.12
LV121 0.5 8 2 0.5 0.06 0.03 1 4 0.5 0.25 >128 0.12 2 0.25 64 0.25
L. fermentum LF71 2 64 32 2 8 0.12 0.06 4 0.25 0.25 >128 0.25 2 1 8 1
LF72 4 64 32 2 8 0.25 0.06 4 0.25 0.5 >128 0.5 2 16 16 0.5
L. casei LP71 8 64 32 8 1 0.12 0.25 4 1 0.5 >128 1 2 0.5 4 1
*GEN, gentamicin; KAN, kanamycin; STP, streptomycin; NEO, neomycin; TET, tetracycline; ERY, erythromycin; CLI, clindamycin; CHL, chloramphenicol; AMP,
ampicillin; PEN, penicillin; VAN, vancomycin; VIR, virginiamycin; LIN, linezolid; TRM, trimethoprim; CIP, ciprofloxacin; RIF, rifampicin.
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the L. gasseri strains (which did not grow in the presence of lac-
tose) all showed high β-galactosidase activity. The L. vaginalis
strains showed strong α-galactosidase activity, but so too did the
L. reuteri and L. fermentum strains. The L. casei strain returned
the highest α-glucosidase activity in presence of maltose.
Table 4 shows the strains’ ability to grow in and acidify
milk. After 24 h of incubation, the cell counts of all the strains
increased slightly, but the figures for most (particularly L. vagi-
nalis and L. fermentum) fell by 48 h. The exceptions were the
L. reuteri strains, which reached values of around 2 × 108 cfu/ml,
and the L. casei strain, which showed the highest viable count
(1 × 109 cfu/ml) and the lowest pH at both sampling points. As
expected, the titratable acidity followed an inverse trend with
respect to pH, increasing as the pH decreased. A titratable acidity
of around 81% of lactic acid equivalent after 48 h of incubation
was recorded for L. casei LC71.
DISCUSSION
The acidic environment of the gastric lumen limits the latter’s
microbial colonization to acidophilic and acid-resistant bacteria.
Among these, different LAB species belonging mainly to the gen-
era Lactobacillus and Streptococcus have been described (Adamson
et al., 1999; Ross et al., 2005; Ryan et al., 2008a; Delgado et al.,
2013). In this study, members of the genus Lactobacillus isolated
from the stomach of healthy humans (see Delgado et al., 2013)
were studied. Four out of the five Lactobacillus species exam-
ined (L. gasseri, L. fermentum, L. vaginalis and L. reuteri) have
also been isolated from human gastric biopsies by other authors
(Ryan et al., 2008a), which strongly suggests that they are com-
mon inhabitants of the gastric environment. Different strains
belonging to the same species in a single individual were detected
only occasionally. Based on the typing results, ten different strains
were considered; these were characterized for their technological
and probiotic properties. In general, they showed good tolerance
and survival at low pH, indicating their capacity to survive in the
human stomach. However, resistance to low pHs for longer peri-
ods of time (and colonization of the gastric epithelium) would be
required to ensure persistence in the human stomach. Resistance
to acidic conditions is a property of interest for the design and for-
mulation of probiotic cultures. Such an ability would allow not
only survival in the upper gastrointestinal tract, but also in fer-
mented products (the most common vehicle for probiotics). The
molecular mechanisms involved in such intrinsic resistance are
currently unknown. The contribution of urease activity to this
resistance however can be ruled out since all the present strains
proved to be urease-negative (data not shown).
Since duodenogastric biliary reflux occasionally occurs, strains
could also be resistant to bile. In fact, high resistance to bovine bile
in lactobacilli strains from the gastric ecosystem has already been
reported (Ryan et al., 2008a). Among the strains of this study,
the L. reuteri proved to be the most resistant to Ox-gall. In con-
trast, as described for intestinal L. gasseri isolates (Delgado et al.,
2007), the gastric strains of this species were rather susceptible
to bile.
Table 4 | Growth and acidification of UHT milk by gastric lactobacilli
strains.
Species Strains Cell counts pH† Titratable
(cfu/ml)* acidity‡
24h 48h 24h 48 h 24h 48h
L. reuteri LR32 4.1 × 107 2.1 × 108 6.02 5.75 21.5 24.0
LR34 3.1 × 107 2.4 × 108 6.09 5.72 22.0 29.0
L. vaginalis LV51 2.5 × 107 1.6 × 107 6.49 6.45 19.0 20.0
LV121 1.5 × 107 2.5 × 106 6.50 6.49 19.0 21.0
L. fermentum LF71 2.0 × 107 9.9 × 106 5.88 5.28 23.5 34.5
LF72 3.7 × 107 3.1 × 107 5.95 5.53 23.5 33.0
L. casei LC71 1.2 × 108 1.3 × 109 5.35 4.01 33.5 81.0
*Inoculum ≈ 1 × 107 cfu/ml.
†pH of the uninoculated milk 6.57.
‡The titratable acidity is expressed as % lactic acid; uninoculated milk 18% lactic
acid.
Table 3 | Glycosidic activities of the Lactobacillus strains determined in cell-free extracts using p-nitrophenyl derivatives.
Species Strain Activity (mU*/mg protein)
α-glucosidase α-glucosidase β-galactosidase α-galactosidase α-galactosidase
(maltose) (trehalose) (lactose) (melibiose) (raffinose)
L. gasseri LG52 – 36 – – –
LG102 – – – – –
LG123 <0.5 – – – –
L. reuteri LR32 <0.5 <0.5 865 63 8
LR34 <0.5 – 574 6 24
L. vaginalis LV51 12 – 551 1368 109
LV121 <0.5 – 248 1170 106
L. fermentum LF71 <0.5 – 145 795 12
LF72 <0.5 – 318 2 96
L. casei LC71 33 <0.5 86 – –
*The enzymatic Unit was defined as the amount of protein that releases 1 μmol of p-NP per min.
−OD 600 nm less than 0.7; activity was, therefore, not determined.
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The strains were shown to adhere to gastric epithelial cells
just as well, or even better than, the well-recognized adher-
ent strain L. rhamnosus GG (Tuomola and Salminen, 1998).
However, comparison of the results with those reported on the
literature is difficult given the use of different cell lines (mostly
colorectal Caco-2 and HT-29) and different cell-to-bacteria ratios
employed.
Probiotics may be useful in the treatment of gastric dysbiosis,
such as those caused by H. pylori infections. In fact, several stud-
ies have reported an inhibitory effect of probiotic lactobacilli on
colonization and development of this pathogen (Johnson-Henry
et al., 2004; Sykora et al., 2005; Francavilla et al., 2008). H. pylori
colonizes the epithelium of the stomach and duodenum, occa-
sionally invading the cells. Colonization seems to reduce systemic
and cellular antioxidative defenses (Hütt et al., 2009). The antiox-
idative potential of the strains was therefore tested, a property that
has already been reported for certain lactobacilli strains (Kullisaar
et al., 2002). According to Hütt et al. (2006), total antioxidative
(TAA) values >20% are considered noteworthy. In the present
work, two strains, L. reuteri LR32 and L. vaginalis LV51, met this
criterion. This protective property may be useful as a defense
mechanism for the gastric mucosa, preserving the tissue from
oxidant-induced damage.
The gastric lactobacilli were also screened for their antimicro-
bial activities against Gram-positive and Gram-negative bacteria.
The production of bacteriocin-like inhibitory substances varies
widely among LAB species and strains (de Vuyst and Leroy,
2007). After successive solid and liquid medium assays, a single
L. gasseri strain (LG52) was consistently shown to be bacteriocin
producer. However, whether LG52 produces an active bacteriocin
under gastric conditions remains yet to be investigated. Another
potential source of inhibitory effects is H2O2, which in certain
environments might be more important than the production
of organic acids. The stomach is a microaerobic environment
and the production of H2O2 might be greater under such con-
ditions than in anaerobiosis. This prompted us to evaluate the
production of H2O2 under aerobic and anaerobic conditions. The
two L. reuteri strains and L. vaginalis LV51 were shown to pro-
duce this compound under both conditions. These strains must
have H2O2 detoxification mechanisms that allow them to protect
themselves from its toxic effects. Superoxide dismutases, peroxi-
dases and dehydrogenases are all able to degrade H2O2,and have
been described in lactobacilli species (Kullisaar et al., 2002; Hütt
et al., 2006; Martín and Suárez, 2010). These enzymes contribute
toward the antioxidative cell defense system. In the present work,
the strains with the largest H2O2 production capacity were those
with the greatest antioxidative activity.
The inhibition of H. pylori by the two L. reuteri strains was
probably due to the production of reuterin; certainly, a gene
essential for its production was detected. Reuterin is a potent
antimicrobial agent that inhibits both Gram-positive and Gram-
negative bacteria. L. reuteri also produces other potent antimi-
crobial compounds, such as reutericin 6 and reutericyclin, but
these have no effects on Gram-negative bacteria (Gänzle, 2004).
The inhibition of H. pylori by lactobacilli has already been
reported (Sgouras et al., 2004; Hütt et al., 2006; López-Brea et al.,
2008; Ryan et al., 2008b). However, most authors attribute the
observed inhibitory effects to live metabolizing cells. In contrast,
the present work provides evidence of the inhibitory effect of
L. reuteri culture supernatants against H. pylori. Wherever this
inhibitory activity comes from, the potential use of these human
stomach-derived L. reuteri strains as probiotics for protecting
against H. pylori infection should be considered.
While L. gasseri seems to be more prevalent in the gastric
ecosystem than L. reuteri, the strains of the latter species displayed
more probiotic-relevant properties and/or higher activity levels.
The antimicrobial—and especially anti-H. pylori—activity of the
L. reuteri strains, together with their antioxidative effects, might
allow them to protect the gastric mucosa from infection and dam-
age. The L. reuteri strains also showed some technological traits
that would allow their inclusion in fermented dairy products.
Strains of other species further showed desirable traits to be rec-
ommended as probiotic candidates. As an example, L. vaginalis
LV51 showed the strongest α-galactosidase activity. This would
be highly desirable in soy-derived products to hydrolyse the α-
galactosides (mainly raffinose and stachyose) capable of causing
gastrointestinal discomfort and flatulence (LeBlanc et al., 2008).
CONCLUSIONS
In summary, this work reports a genotypic, technological and
probiotic description and characterization of a group of lacto-
bacilli from the human stomach. In vitro, some of the gastric
strains (particularly the L. reuteri strains) showed a vast array
of desirable properties to be considered as promising probiotic
candidates. Additionally, they showed appropriate technological
traits to be included in dairy or other fermented functional foods
as adjunct cultures. The efficacy of such probiotics for the treat-
ment and/or prevention of gastric microbial dysbiosis should be
carefully evaluated in vivo through controlled clinical trials.
AUTHOR CONTRIBUTIONS
Susana Delgado and Baltasar Mayo contributed with the con-
ception and design of the study. Susana Delgado and Analy
M. O. Leite were involved in the experimental determinations.
Patricia Ruas-Madiedo was in charge of the adhesion experi-
ments and in the maintenance of the gastric cell line. Susana
Delgado and Baltasar Mayo interpreted the data and drafted the
manuscript. Patricia Ruas-Madiedo performed a critical revision
of the manuscript. All authors approved the final version of the
article.
ACKNOWLEDGMENTS
This research was funded by projects from the SpanishMinistry of
Economy and Competitiveness and Innovation (Ref. AGL2011-
24300) and FICYT (Ref. IB08-005). Susana Delgado was sup-
ported by a contract under Juan de la Cierva program (Ref.
JCI-2008-02391). The technical assistance of Elena Fernández and
Alicia Noriega is greatly acknowledged.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/journal/10.3389/fmicb.2014.
00766/abstract
www.frontiersin.org January 2015 | Volume 5 | Article 766 | 7
Delgado et al. Gastric lactobacilli characterization
REFERENCES
Adamson, I., Nord, C. E., Lundquist, P., Sjöstedt, S., and Edlund, C. (1999).
Comparative effects of omeprazole, amoxycillin plus metronidazole versus
omeprazole, clarithromycin plus metronidazole on the oral, gastric and intesti-
nal microflora inHelicobacter pylori-infected patients. J. Antimicrob. Chemother.
44, 629–640.
Andersson, A., Lindberg, M., Jakobsson, H., Bäckhed, F., Nyrén, P., and Engstrand,
L. (2008). Comparative analysis of human gut microbiota by barcoded pyrose-
quencing. PLoS ONE 3:e2836. doi: 10.1371/journal.pone.0002836
Bik, E. M., Eckburg, P. B., Gill, S. R., Nelson, K. E., Purdom, E. A., Francois,
F., et al. (2006). Molecular analysis of the bacterial microbiota in the human
stomach. Proc. Natl. Acad. Sci. U.S.A. 103, 732–737. doi: 10.1073/pnas.0506
655103
Bruce, M. G., and Maaroos, H. I. (2008). Epidemiology ofHelicobacter pylori infec-
tion. Helicobacter 13(Suppl. 1), 1–6. doi: 10.1111/j.1523-5378.2008.00631.x
Charteris, W. P., Kelly, P. M., Morelli, L., and Collins, J. K. (1998). Development
and application of an in vivo methodology to determine the transit tolerance
of potentially probiotic Lactobacillus and Bifidobacterium species in the upper
human gastrointestinal tract. J. Appl. Microbiol. 84, 759–768.
Claisse, O., and Lonvaud-Funel, A. (2001). Primers and a specific DNA probe
for detecting lactic acid bacteria producing 3-hydroxypropionaldehyde from
glycerol in spoiled ciders. J. Food Protect. 64, 833–837.
Cui, Y., Wang, C. L., Liu, X. W., Wang, X. H., Chen, L. L., Zhao, X., et al.
(2010). Two stomach-originated Lactobacillus strains improve Helicobacter
pylori infected murine gastritis. World J. Gastroenterol. 28, 445–452. doi:
10.3748/wjg.v16.i4.445
Delgado, S., Cabrera-Rubio, R., Mira, A., Suárez, A., and Mayo, B. (2013).
Microbiological survey of the human gastric ecosystem using culturing and
pyrosequencing methods. Microbial. Ecol. 65, 763–772. doi: 10.1007/s00248-
013-0192-5
Delgado, S., O’Sullivan, E., Fitzgerald, G., and Mayo, B. (2007). Subtractive screen-
ing for probiotic properties of Lactobacillus species from the human gastroin-
testinal tract in the search for new probiotics. J. Food Sci. 72, M310–M315. doi:
10.1111/j.1750-3841.2007.00479.x
de Vuyst, L., and Leroy, F. (2007). Bacteriocins from lactic acid bacteria: production,
purification, and food applications. J. Mol. Microbiol. Biotechnol. 13, 194–199.
doi: 10.1159/000104752
EFSA. (2012). Guidance on the assessment of bacterial susceptibility to antimicro-
bials of human and veterinary importance. EFSA J. 10, 2740–2749.
Francavilla, R., Lionetti, E., Castellaneta, S. P., Magistà, A. M., Maurogiovanni,
G., Bucci, N., et al. (2008). Inhibition of Helicobacter pylori infection in
humans by Lactobacillus reuteri ATCC 55730 and effect on eradication ther-
apy: a pilot study. Helicobacter 13, 127–134. doi: 10.1111/j.1523-5378.2008.
00593.x
Gänzle, M. G. (2004). Reutericyclin: biological activity, mode of action, and poten-
tial applications. Appl. Microbiol. Biotechnol. 64, 326–332. doi: 10.1007/s00253-
003-1536-8
Hütt, P., Andreson, H., Kullisaar, T., Vihalemm, T., Unt, E., Kals, J., et al.
(2009). Effects of a synbiotic product on blood antioxidative activity in sub-
jects colonized with Helicobacter pylori. Lett. Appl. Microbiol. 48, 797–800. doi:
10.1111/j.1472-765X.2009.02607.x
Hütt, P., Shchepetova, J., Lõivukene, K., Kullisaar, T., and Mikelsaar, M. (2006).
Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero-
and uropathogens. J. Appl. Microbiol. 100, 1324–1332. doi: 10.1111/j.1365-
2672.2006.02857.x
Johnson-Henry, K. C., Mitchell, D. J., Avitzur, Y., Galindo-Mata, E., Jones, N. L.,
and Sherman, P. M. (2004). Probiotics reduce bacterial colonization and gas-
tric inflammation in H. pylori-infected mice. Dig. Dis. Sci. 49, 1095–1102. doi:
10.1023/B:DDAS.0000037794.02040.c2
Klare, I., Konstabel, C., Müller-Bertling, S., Reissbrodt, R., Huys, G., Vancanneyt,
M., et al. (2005). Evaluation of new broth media for microdilution antibiotic
susceptibility testing of lactobacilli, lactococci, pediococci, and bifidobacte-
ria. Appl. Environ. Microbiol. 71, 8982–8986. doi: 10.1128/AEM.71.12.8982-
8986.2005
Koeuth, T., Versalovic, J., and Lupski, J. R. (1995). Differential subsequence con-
servation of interspersed repetitive Streptococcus pneumoniae BOX elements in
diverse bacteria. Genome Res. 5, 408–418.
Kullisaar, T., Zilmer, M., Mikelsaar, M., Vihalemm, T., Annuk, H., Kairane, C., et al.
(2002). Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food
Microbiol. 72, 215–224. doi: 10.1016/S0168-1605(01)00674-2
LeBlanc, J. G., Ledue-Clier, F., Bensaada, M., de Giori, G. S., Guerekobaya, T.,
Sesma, F., et al. (2008). Ability of Lactobacillus fermentum to overcome host
alpha-galactosidase deficiency, as evidenced by reduction of hydrogen excretion
in rats consuming soya alpha-galacto-oligosaccharides. BMC Microbiol. 8:22.
doi: 10.1186/1471-2180-8-22
Li, X. X., Wong, G. L. H., To, K. F., Wong, V. W. S., Lai, L. H., Chow, D. K. L., et al.
(2009). Bacterial microbiota profiling in gastritis without Helicobacter pylori
infection or non-steroidal anti-inflammatory drug use. PLoS ONE 4:e7985. doi:
10.1371/journal.pone.0007985
López-Brea, M., Alarcón, T., Domingo, D., and Díaz-Regañón, J. (2008).
Inhibitory effect of Gram-negative and Gram-positive microorganisms against
Helicobacter pylori clinical isolates. J. Antimicrob. Chemother. 61, 139–142. doi:
10.1093/jac/dkm404
Malfertheiner, P., Megraud, F., O’Morain, C., Bazzoli, F., El-Omar, E., Graham,
D., et al. (2007). Current concepts in the management of Helicobacter
pylori infection: the Maastricht III consensus report. Gut 56, 772–781. doi:
10.1136/gut.2006.101634
Martín, R., Olivares, M., Marín, M. L., Xaus, J., Fernández, L., and Rodríguez, J.
M. (2005). Characterization of a reuterin-producing Lactobacillus coryniformis
strain isolated from a goat’s milk cheese. Int. J. Food Microbiol. 104, 267–277.
doi: 10.1016/j.ijfoodmicro.2005.03.007
Martín, R., and Suárez, J. E. (2010). Biosynthesis and degradation of H2O2 by
vaginal lactobacilli. Appl. Environ. Microbiol. 76, 400–405. doi: 10.1128/AEM.
01631-09
Peek, R. M., and Blaser, M. J. (2002). Helicobacter pylori and gastrointestinal tract
adenocarcinomas. Nat. Rev. Cancer 2, 28–37. doi: 10.1038/nrc703
Ross, S., Engstrand, L., and Jonsson, H. (2005). Lactobacillus gastricus sp. nov.,
Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus
ultunensis sp. nov., isolated from human stomach mucosa. Int. J. Syst. Evol.
Microbiol. 55, 77–82. doi: 10.1099/ijs.0.63083-0
Ryan, K. A., Daly, P., Li, Y., Hooton, C., and O’Toole, P. W. (2008b). Strain-specific
inhibition ofHelicobacter pylori by Lactobacillus salivarius and other lactobacilli.
J. Antimicrob. Chemother. 61, 831–834. doi: 10.1093/jac/dkn040
Ryan, K. A., Jarayaman, T., Daly, P., Canchaya, C., Curran, S., Fang, F., et al. (2008a).
Isolation of lactobacilli with probiotic properties from the human stomach. Lett.
Appl. Microbiol. 47, 269–274. doi: 10.1111/j.1472-765X.2008.02416.x
Sgouras, D., Maragkoudakis, P., Petraki, K., Martinez-Gonzalez, B., Eriotou, E.,
Michopoulos, S., et al. (2004). In vitro and in vivo inhibition of Helicobacter
pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70, 518–526.
doi: 10.1128/AEM.70.1.518-526.2004
Song, Y. L., Kato, N., Matsumiya, Y., Liu, C. X., Kato, H., and Watanabe, K. (1999).
Identification of and hydrogen peroxide production by fecal and vaginal lacto-
bacilli isolated from Japanese women and newborn infants. J. Clin. Microbiol.
37, 3062–3064.
Sykora, J., Valeckova, K., Amlerova, J., Siala, K., Dedek, P., Watkins, S., et al. (2005).
Effects of a specially designed fermented milk product containing probiotic
Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a
prospective randomized double-blind study. J. Clin. Gastroenterol. 39, 692–698.
doi: 10.1097/01.mcg.0000173855.77191.44
Tuomola, E. M., and Salminen, S. J. (1998). Adhesion of some probiotic and dairy
Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 41, 45–51.
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 31 October 2014; accepted: 16 December 2014; published online: 14 January
2015.
Citation: Delgado S, Leite AMO, Ruas-Madiedo P and Mayo B (2015) Probiotic and
technological properties of Lactobacillus spp. strains from the human stomach in the
search for potential candidates against gastric microbial dysbiosis. Front. Microbiol.
5:766. doi: 10.3389/fmicb.2014.00766
This article was submitted to Food Microbiology, a section of the journal Frontiers in
Microbiology.
Copyright © 2015 Delgado, Leite, Ruas-Madiedo and Mayo. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | Food Microbiology January 2015 | Volume 5 | Article 766 | 8
